Molecular subtyping of cholangiocarcinoma and its potential clinical application
10.3760/cma.j.cn113884-20210413-00135
- VernacularTitle:肝内胆管癌的分子分型及其临床应用研究进展
- Author:
Jingshu TONG
1
;
Yeming ZHOU
;
Caide LU
;
Changjiang LU
;
Jing HUANG
Author Information
1. 宁波大学医学院,宁波 315211
- Keywords:
Cholangiocarcinoma;
Molecular typing;
Clinical application;
Progress
- From:
Chinese Journal of Hepatobiliary Surgery
2021;27(12):954-957
- CountryChina
- Language:Chinese
-
Abstract:
Intrahepatic cholangiocarcinoma (ICC) has a high degree malignancy, and its incidence has gradually increased in recent years. Surgery is still the only curative treatment for ICC to achieve long-term survival, but its onset is hidden, and most patients have lost the opportunity of operation when they are diagnosed. ICC shows significant heterogeneity. With the development of the second generation sequencing technology, the tumor patterns of ICC, such as DNA, RNA, epigenetic, protein, microenvironment and so on, have been gradually discovered. The purpose of this article is to review the research progress of molecular typing and clinical application of ICC in recent years.